Sterling Capital Management’s Ascendis Pharma A/S ASND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.41M Sell
14,929
-9,880
-40% -$2.21M 0.06% 231
2025
Q4
$5.29M Buy
24,809
+25
+0.1% +$5.16K 0.09% 188
2025
Q3
$4.93M Sell
24,784
-29,725
-55% -$5.54M 0.07% 190
2025
Q2
$9.41M Buy
54,509
+3,432
+7% +$559K 0.13% 104
2025
Q1
$7.96M Sell
51,077
-5,773
-10% -$825K 0.12% 104
2024
Q4
$7.83M Buy
56,850
+9,065
+19% +$1.19M 0.11% 120
2024
Q3
$7.13M Buy
+47,785
New +$6.45M 0.09% 148
2019
Q3
$5.83M Buy
60,580
+5,830
+11% +$650K 0.06% 228
2019
Q2
$6.3M Buy
54,750
+12,790
+30% +$1.53M 0.06% 228
2019
Q1
$4.94M Buy
+41,960
New +$3.67M 0.05% 244
2015
Q2
Sell
-19,452
Closed -$337K 879
2015
Q1
$337K Buy
+19,452
New +$354K ﹤0.01% 768

Other funds holding ASND